The sorafenib anti-relapse effect after alloHSCT is associated with heightened alloreactivity and accumulation of CD8+PD-1+ (CD279+) lymphocytes in marrow

Inhibition of FLT3 in AML: a focus on sorafenib

(2016) A Antar et al.   BONE MARROW TRANSPLANTATION

Sorafenib-resistant hepatocellular carcinoma stratified by phosphorylated ERK activates PD-1 immune checkpoint

(2016) Jiang Chen et al.   Oncotarget

Improvement in clinical outcome ofFLT3ITD mutated acute myeloid leukemia patients over the last one and a half decade

(2015) Talha Badar et al.   AMERICAN JOURNAL OF HEMATOLOGY

T-cell exhaustion in the tumor microenvironment

(2015) Y Jiang et al.   Cell Death & Disease

Current Approaches in the Treatment of Relapsed and Refractory Acute Myeloid Leukemia

(2015) Nestor Ramos et al.   Journal of Clinical Medicine

Phase I Trial of Maintenance Sorafenib after Allogeneic Hematopoietic Stem Cell Transplantation for Fms-like Tyrosine Kinase 3 Internal Tandem Duplication Acute Myeloid Leukemia

(2014) Yi-Bin Chen et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Myeloid-Derived Suppressor Cells as Therapeutic Target in Hematological Malignancies

(2014) Kim De Veirman et al.   Frontiers in Oncology

Acute myeloid leukemia: 2013 update on risk-stratification and management

(2013) Elihu H. Estey   AMERICAN JOURNAL OF HEMATOLOGY

The mTOR pathway and integrating immune regulation

(2013) Stephen P. Cobbold   IMMUNOLOGY

mTORC1 couples immune signals and metabolic programming to establish Treg-cell function

(2013) Hu Zeng et al.   NATURE

Impact of FLT3 Internal Tandem Duplication on the Outcome of Related and Unrelated Hematopoietic Transplantation for Adult Acute Myeloid Leukemia in First Remission: A Retrospective Analysis

(2012) Salut Brunet et al.   JOURNAL OF CLINICAL ONCOLOGY

Ragulator-Rag Complex Targets mTORC1 to the Lysosomal Surface and Is Necessary for Its Activation by Amino Acids

(2010) Yasemin Sancak et al.   CELL

The multikinase inhibitor Sorafenib reverses the suppression of IL-12 and enhancement of IL-10 by PGE2 in murine macrophages

(2010) Justin P. Edwards et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Sorafenib – a small molecule with big promise?

(2010) Tamar Tadmor et al.   LEUKEMIA & LYMPHOMA

Foxo proteins cooperatively control the differentiation of Foxp3+ regulatory T cells

(2010) Weiming Ouyang et al.   NATURE IMMUNOLOGY

Reactivations of Cytomegalovirus, Human Herpes Virus 6, and Epstein-Barr Virus Differ with Respect to Risk Factors and Clinical Outcome after Hematopoietic Stem Cell Transplantation

(2010) E. Jaskula et al.   TRANSPLANTATION PROCEEDINGS

Management of relapse after allo-SCT for AML and the role of second transplantation

(2009) B N Savani et al.   BONE MARROW TRANSPLANTATION

The PI3K/Akt/mTOR pathway in innate immune cells: emerging therapeutic applications

(2008) T Weichhart et al.   ANNALS OF THE RHEUMATIC DISEASES

Potential role of sorafenib in the treatment of acute myeloid leukemia

(2008) Shahram Mori et al.   LEUKEMIA & LYMPHOMA